Esophageal cancer: improved prognosis with neoadjuvant chemoradiotherapy

被引：0
|
作者：
Knippen, Stefan [1 ]
Duma, Marciana-Nona [1 ]
机构：
[1] Univ Klinikum Jena, Klin Strahlentherapie & Radioonkol, Bachstr 18, D-07745 Jena, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2022年 / 198卷 / 01期
关键词：
CONFORMAL RADIOTHERAPY; CHEMOTHERAPY; SURGERY;
D O I：
10.1007/s00066-021-01881-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：86 / 88
页数：3
相关论文
共 50 条
  • [21] Neoadjuvant chemoradiotherapy for esophageal cancer - a single institution experience
    Ermenc, A. Secerov
    Anderluh, F.
    Peressutti, A. Jeromen
    Velenik, V.
    Oblak, I.
    Korosec, P.
    Hadzic, J. But
    Pulko, N.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1095 - S1095
  • [22] Present status and progress of neoadjuvant chemoradiotherapy for esophageal cancer
    Liu, Jing
    Yue, Jinbo
    Xing, Ligang
    Yu, Jinming
    FRONTIERS OF MEDICINE, 2013, 7 (02) : 172 - 179
  • [23] CD44 expression is associated with unfavorable prognosis in esophageal cancer patients undergoing neoadjuvant chemoradiotherapy
    Yoshikawa, Reigetsu
    Tsujimura, Tohru
    Tao, Lihua
    Kaibe, Nobuaki
    Sasako, Mitsuru
    Fujiwara, Yoshinori
    CANCER RESEARCH, 2009, 69
  • [24] Neoadjuvant chemoradiotherapy for esophageal carcinoma
    Zhang, X
    Watson, DI
    Jamieson, GG
    Bessell, JR
    Devitt, PG
    DISEASES OF THE ESOPHAGUS, 2005, 18 (02) : 104 - 108
  • [25] Multimodal Therapy of Esophageal Cancer Neoadjuvant Chemotherapy vs. neoadjuvant Chemoradiotherapy
    Hoeppner, Jens
    ONKOLOGE, 2016, 22 (07): : 509 - 510
  • [26] Comparison of neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for esophageal cancer: a meta-analysis
    Jing, Shao-wu
    Qin, Jian-jun
    Liu, Qing
    Zhai, Chang
    Wu, Ya-jing
    Cheng, Yun-jie
    Czito, Brian G.
    Wang, Jun
    FUTURE ONCOLOGY, 2019, 15 (20) : 2413 - 2422
  • [27] A Review of CROSS Neoadjuvant Chemoradiotherapy for Esophageal Cancer in Malaysian Patients
    Salimin, Norhidayu
    RADIOTHERAPY AND ONCOLOGY, 2024, 197 : S276 - S277
  • [28] Outcomes according to radiation fields of neoadjuvant chemoradiotherapy for esophageal cancer
    Choi, N.
    Jeon, W.
    Kang, H. C.
    Kim, H. J.
    Kim, S.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S772 - S772
  • [29] High lymphocyte count during neoadjuvant chemoradiotherapy is associated with improved pathologic complete response in esophageal cancer
    Fang, Penny
    Jiang, Wen
    Davuluri, Rajayogesh
    Xu, Cai
    Krishnan, Sunil
    Mohan, Radhe
    Koong, Albert C.
    Hsu, Charles C.
    Lin, Steven H.
    RADIOTHERAPY AND ONCOLOGY, 2018, 128 (03) : 584 - 590
  • [30] Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Review of Meta-Analyses
    Wijnhoven, Bas P. L.
    van Lanschot, Jan J. B.
    Tilanus, Hugo W.
    Steyerberg, Ewout W.
    van der Gaast, Ate
    WORLD JOURNAL OF SURGERY, 2009, 33 (12) : 2606 - 2614
12345